Clinical Course and Outcome of Human Monkeypox in Nigeria
Dimie OgoinaInfectious Disease Unit, Niger Delta University Teaching Hospital, Okolobiri, Bayelsa, NigeriaMichael IroezinduInfectious Disease Unit, Federal Medical Centre Owerri/University of Nigeria Teaching Hospital, Enugu, NigeriaHendris Izibewule JamesInfectious Disease Unit, Niger Delta University Teaching Hospital, Okolobiri, Bayelsa, NigeriaRegina OladokunPaediatric Infectious Disease Unit, University College Hospital, Ibadan, Oyo State, NigeriaAdesola Yinka-OgunleyeNigerian Centre for Disease Control, Abuja, Federal Capital Territory, NigeriaPaul WakamaNigerian Prison Services, Port Harcourt, Rivers State, NigeriaBolaji Otike-OdibiDepartment of Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers State, NigeriaLiman Muhammed UsmanEmmanuel ObazeeDepartment of Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers State, NigeriaOlusola ArunaGlobal Public Health Department, Public Health England, London, United KingdomChikwe IhekweazuNigerian Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria
2020en
ABI
Annotatsiya
In a retrospective review of hospital records of 40 human monkeypox cases from Nigeria, the majority developed fever and self-limiting vesiculopustular skin eruptions. Five deaths were reported. Compared to human immunodeficiency virus (HIV)-negative cases, HIV type 1-coinfected cases had more prolonged illness, larger lesions, and higher rates of both secondary bacterial skin infections and genital ulcers.
Hali tarjima qilinmagan
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba